The Role of Circulating Biomarkers in the Oncological Management ...

Circulating tumor cells (CTCs) can be found in liquid biopsies from metastatic RCC patients, potentially providing a better representation of ...

Circulating biomarkers, such as circulating tumor DNA, noncoding RNA, proteins, extracellular vesicles, or cancer cells themselves potentially ...

[PDF] The Role of Circulating Biomarkers in the Oncological ...

The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now? · A. Cinque, A. Capasso, +3 authors

(PDF) The Role of Circulating Biomarkers in the Oncological ...

Circulating biomarkers, such as circulating tumor DNA, noncoding RNA, proteins, extracellular vesicles, or cancer cells themselves potentially represent a ...

Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer ...

In this review, the roles of various circulating biomarkers in monitoring treatment response are described. Non-specific markers of disease ...

The Role of Circulating Biomarkers in Lung Cancer - Frontiers

Graphical Abstract The identification of multi-marker analytes in liquid biopsy samples enables a personalised medicine approach to the management of lung ...

Circulating Biomarkers in Breast Cancer - ScienceDirect.com

The clinical use of current serum biomarkers alone in identifying disease progression and response to therapy is limited. Thus, there is a need to identify ...

The Role of Circulating Biomarkers in the Early Detection of ...

On a global scale, colorectal cancer (CRC) is currently the fourth most commonly diagnosed cancer and despite progress in early diagnosis and treatment has the ...

Circulating Cardiovascular Biomarkers in Cancer Therapeutics ...

Preventative and therapeutic strategies to avoid withholding of cancer therapy are available including treatment of underlying risk factors, ...

Circulating Biomarkers in Breast Cancer

Circulating biomarkers have the potential to provide valuable insight into disease progression and response to therapy, and they can serve to identify ...

Special Issue : Circulating Biomarkers in Cancer - MDPI

This Special Issue will highlight the role of circulating biomarkers in cancer as a revolutionary tool for cancer management, covering both basic and ...

Blood-based circulating biomarkers for prediction of immune ...

These biomarkers, including circulating immune cells, soluble factors, tumor-derived markers, and those based on metabolomics, are less invasive, offer ...

Predictive and On-Treatment Monitoring Role of Circulating ...

The growing expansion of immuno-oncology has led to identify and implement the viability of predictive and on-treatment biomarkers to ...

Circulating biomarkers in perioperative management of cancer ...

Multi-omic networks are altered in the perioperative period and influence cancer progression, and the following circulating biomarkers are noteworthy: PEDF, IL- ...

Circulating biomarkers in cancer care: What possible use?

The ultimate goal of precision medicine is that all patients will be tested for multiple predictive markers so that each patient will receive the treatment from ...

The Role of Circulating Biomarkers in the Oncological Management ...

Renal cell carcinoma (RCC) is an increasingly common malignancy that can progress to metastatic renal cell carcinoma (mRCC) in approximately one-third of ...

Prognostic and predictive significance of circulating biomarkers in ...

Biomarkers have been introduced into clinical practice for cancer management. This study aimed to investigate the predictive and prognostic ...

The current role of circulating biomarkers in non-muscle invasive ...

In general, up to 70% of NMIBC patients eventually present with disease recurrence and 10–20% experience disease progression to muscle invasive bladder cancer ( ...

Circulating Biomarkers of Response to Immunotherapy in Cancer ...

Circulating tumor cells (CTCs) have been used to characterize tumor and PD-L1 dynamics during treatment, confirming that a considerable heterogeneity exists in ...

Circulating Biomarkers in Breast Cancer

informed management. This review will evaluate the roles of circulating biomarkers in breast cancer, including the serum markers Carcinoembryonic antigen ...